To access this element change to forms mode OFF
Grant Award View - GA65891
Mechanism-based treatments for chemotherapy-induced pain
GA ID:
GA65891
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2023
Value (AUD):
$812,662.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
Mechanism-based treatments for chemotherapy-induced pain
Purpose:
Vincristine, an essential chemotherapy agent used for the treatment of many types of cancer, causes severe dose limiting side effects including pain and peripheral nerve damage. The aim of this project is define the mechanisms of vincristine-induced neuropathy in order to development novel treatment approaches.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1186835
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD
Postcode:
Country:
AUSTRALIA